Why the study?
Are specific pharmacological, behavioral, and surgical therapies cost-effective in managing heart failure?
Population
Patients with heart failure
Design
Review
Authors
Loading...
Supports value-based HF therapy selection now; extends outcome data with economic synthesis for future analyses.
Are specific pharmacological, behavioral, and surgical therapies cost-effective in managing heart failure?
Various established heart failure therapies, including specific medications, multidisciplinary teams, and transplantation, are cost-effective and may even yield net cost savings.
Rich et al. (1999) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: